Next, we analyzed the relationship between the expression of CDC20 and the prognosis of HCC patients, and the results indicated that high CDC20 expression was correlated with poor overall survival (OS) (Figure 1C), disease-free survival (DFS) (Figure 1D), and progression-free survival (PFS) in HCC (Figure 1E). This evidence concerns the gene CDC20 and hepatocellular carcinoma.